(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 5.36% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.38%.
Qiagen Nv's revenue in 2025 is $2,002,874,000.On average, 7 Wall Street analysts forecast QGEN's revenue for 2025 to be $448,526,881,400, with the lowest QGEN revenue forecast at $447,042,269,700, and the highest QGEN revenue forecast at $450,706,778,990. On average, 7 Wall Street analysts forecast QGEN's revenue for 2026 to be $475,504,365,765, with the lowest QGEN revenue forecast at $470,090,757,500, and the highest QGEN revenue forecast at $484,745,311,700.
In 2027, QGEN is forecast to generate $512,511,904,190 in revenue, with the lowest revenue forecast at $505,804,158,600 and the highest revenue forecast at $522,478,829,600.